All Posts
🤚🏻 Five for Friday – 5 Nutrition Resources
Home / Blog / [wpbb post:title] Happy National Nutrition Month! "As a cholangiocarcinoma cancer patient myself, I know how curious…
CCF CARE Teams 2023: Greetings From The Volunteer State
Have you ever wondered how Tennessee became known as the "Volunteer State"? Well, it goes back to the War of…
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
Study Name Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients…
Monthly Scientific Update – March 2023
Asbestos and Cholangiocarcinoma: A Pilot Study Kelly Butler Asbestos is a mineral-derived carcinogen linked to multiple human cancers. Although asbestos…
🤚🏻 Five for Friday – 5 TeamCCF Stories
Home / Blog / [wpbb post:title] TeamCCF began in 2016 as a way to raise money through athletic events for…
🤚🏻 Five for Friday – 5 takeaways from GI ASCO 2023
Home / Blog / [wpbb post:title] The American Society of Clinical Oncology Gastrointestinal Cancers Symposium The American Society of Clinical…
phase 2 basket trial of ulixertinib (BVD-523) in combination with hydroxychloroquine in patients with advanced gastrointestinal malignancies harboring MAPK pathway mutations (BVD-523-HCQ)
Study Name A phase 2 basket trial of ulixertinib (BVD-523) in combination with hydroxychloroquine in patients with advanced gastrointestinal malignancies…
🤚🏻 Five for Friday – 5 Awareness Month Testimonials
Home / Blog / [wpbb post:title] Thank you to all who have supported Cholangiocarcinoma Awareness Month so far. Yesterday, February…
🤚🏻 Five for Friday – 5 pages to review in the CCF Annual Report
Home / Blog / [wpbb post:title] CCF is pleased to share the 2022 Fiscal Year Annual Report highlighting the many…
TCS New York City Marathon
Marathon - Sunday, November 3, 2024 New York, New York The fundraising minimum for the 2024 TCS New York City…